NEW YORK, Sept. 24, 2019 /PRNewswire/ -- Pacira BioSciences Inc. (PCRX) will replace Shutterfly Inc. (SFLY) in the S&P SmallCap 600 effective prior to the open of trading on Monday, September 30. Apollo Global Management Inc. (APO) is acquiring Shutterfly in a transaction expected to be completed tomorrow pending final conditions.
Pacira BioSciences provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients. Headquartered in Parsippany, NJ, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Pharmaceuticals Sub-Industry index.
Following is a summary of the change:
S&P SMALLCAP 600 INDEX – September 30, 2019
GICS ECONOMIC SECTOR
Internet & Direct
For more information about S&P Dow Jones Indices, please visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has become home to over 1,000,000 indices across the spectrum of asset classes that have helped define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.
FOR MORE INFORMATION:
S&P Dow Jones Indices
Index Governance Inquiries